These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 21124314)
1. Prediction of fluoroquinolone-induced elevation in serum creatinine levels: a case of drug-endogenous substance interaction involving the inhibition of renal secretion. Imamura Y; Murayama N; Okudaira N; Kurihara A; Okazaki O; Izumi T; Inoue K; Yuasa H; Kusuhara H; Sugiyama Y Clin Pharmacol Ther; 2011 Jan; 89(1):81-8. PubMed ID: 21124314 [TBL] [Abstract][Full Text] [Related]
2. Interactions of fluoroquinolone antibacterials, DX-619 and levofloxacin, with creatinine transport by renal organic cation transporter hOCT2. Okuda M; Kimura N; Inui K Drug Metab Pharmacokinet; 2006 Oct; 21(5):432-6. PubMed ID: 17072098 [TBL] [Abstract][Full Text] [Related]
3. Renal secretion of hydrochlorothiazide involves organic anion transporter 1/3, organic cation transporter 2, and multidrug and toxin extrusion protein 2-K. Yin J; Wagner DJ; Prasad B; Isoherranen N; Thummel KE; Wang J Am J Physiol Renal Physiol; 2019 Oct; 317(4):F805-F814. PubMed ID: 31322418 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of the potency of telaprevir and its metabolites as inhibitors of renal organic cation transporters, a potential mechanism for the elevation of serum creatinine. Nakada T; Kito T; Inoue K; Masuda S; Inui K; Matsubara K; Moriyama Y; Hisanaga N; Adachi Y; Suzuki M; Yamada I; Kusuhara H Drug Metab Pharmacokinet; 2014; 29(3):266-71. PubMed ID: 24390473 [TBL] [Abstract][Full Text] [Related]
5. Renal tubular secretion of varenicline by multidrug and toxin extrusion (MATE) transporters. Kajiwara M; Masuda S; Watanabe S; Terada T; Katsura T; Inui K Drug Metab Pharmacokinet; 2012; 27(6):563-9. PubMed ID: 22510868 [TBL] [Abstract][Full Text] [Related]
6. Atenolol Renal Secretion Is Mediated by Human Organic Cation Transporter 2 and Multidrug and Toxin Extrusion Proteins. Yin J; Duan H; Shirasaka Y; Prasad B; Wang J Drug Metab Dispos; 2015 Dec; 43(12):1872-81. PubMed ID: 26374172 [TBL] [Abstract][Full Text] [Related]
7. Contribution of the organic anion transporter OAT2 to the renal active tubular secretion of creatinine and mechanism for serum creatinine elevations caused by cobicistat. Lepist EI; Zhang X; Hao J; Huang J; Kosaka A; Birkus G; Murray BP; Bannister R; Cihlar T; Huang Y; Ray AS Kidney Int; 2014 Aug; 86(2):350-7. PubMed ID: 24646860 [TBL] [Abstract][Full Text] [Related]
8. Impact of Substrate-Dependent Inhibition on Renal Organic Cation Transporters hOCT2 and hMATE1/2-K-Mediated Drug Transport and Intracellular Accumulation. Yin J; Duan H; Wang J J Pharmacol Exp Ther; 2016 Dec; 359(3):401-410. PubMed ID: 27758931 [TBL] [Abstract][Full Text] [Related]
9. Involvement of Renal Efflux Transporter MATE1 in Renal Excretion of Flecainide. Doki K; Apáti S; Sakata T; Homma M Biol Pharm Bull; 2019; 42(7):1226-1229. PubMed ID: 31257298 [TBL] [Abstract][Full Text] [Related]
10. Effect of the fluoroquinolone antibacterial agent DX-619 on the apparent formation and renal clearances of 6β-hydroxycortisol, an endogenous probe for CYP3A4 inhibition, in healthy subjects. Imamura Y; Murayama N; Okudaira N; Kurihara A; Inoue K; Yuasa H; Izumi T; Kusuhara H; Sugiyama Y Pharm Res; 2013 Feb; 30(2):447-57. PubMed ID: 23073666 [TBL] [Abstract][Full Text] [Related]
11. Competitive inhibition of the luminal efflux by multidrug and toxin extrusions, but not basolateral uptake by organic cation transporter 2, is the likely mechanism underlying the pharmacokinetic drug-drug interactions caused by cimetidine in the kidney. Ito S; Kusuhara H; Yokochi M; Toyoshima J; Inoue K; Yuasa H; Sugiyama Y J Pharmacol Exp Ther; 2012 Feb; 340(2):393-403. PubMed ID: 22072731 [TBL] [Abstract][Full Text] [Related]
12. Involvement of human multidrug and toxin extrusion 1 in the drug interaction between cimetidine and metformin in renal epithelial cells. Tsuda M; Terada T; Ueba M; Sato T; Masuda S; Katsura T; Inui K J Pharmacol Exp Ther; 2009 Apr; 329(1):185-91. PubMed ID: 19164462 [TBL] [Abstract][Full Text] [Related]
13. Creatinine transport by basolateral organic cation transporter hOCT2 in the human kidney. Urakami Y; Kimura N; Okuda M; Inui K Pharm Res; 2004 Jun; 21(6):976-81. PubMed ID: 15212162 [TBL] [Abstract][Full Text] [Related]
15. Role of organic cation transporter OCT2 and multidrug and toxin extrusion proteins MATE1 and MATE2-K for transport and drug interactions of the antiviral lamivudine. Müller F; König J; Hoier E; Mandery K; Fromm MF Biochem Pharmacol; 2013 Sep; 86(6):808-15. PubMed ID: 23876341 [TBL] [Abstract][Full Text] [Related]
16. Characterization of Organic Anion Transporter 2 (SLC22A7): A Highly Efficient Transporter for Creatinine and Species-Dependent Renal Tubular Expression. Shen H; Liu T; Morse BL; Zhao Y; Zhang Y; Qiu X; Chen C; Lewin AC; Wang XT; Liu G; Christopher LJ; Marathe P; Lai Y Drug Metab Dispos; 2015 Jul; 43(7):984-93. PubMed ID: 25904762 [TBL] [Abstract][Full Text] [Related]
17. Use of a Double-Transfected System to Predict hOCT2/hMATE1-Mediated Renal Drug-Drug Interactions. Vieira LS; Wang J Drug Metab Dispos; 2024 Mar; 52(4):296-304. PubMed ID: 38326034 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of Renal Transporter Inhibition Using Creatinine as a Substrate In Vitro to Assess the Clinical Risk of Elevated Serum Creatinine. Mathialagan S; Rodrigues AD; Feng B J Pharm Sci; 2017 Sep; 106(9):2535-2541. PubMed ID: 28416419 [TBL] [Abstract][Full Text] [Related]
19. Impact on creatinine renal clearance by the interplay of multiple renal transporters: a case study with INCB039110. Zhang Y; Warren MS; Zhang X; Diamond S; Williams B; Punwani N; Huang J; Huang Y; Yeleswaram S Drug Metab Dispos; 2015 Apr; 43(4):485-9. PubMed ID: 25605813 [TBL] [Abstract][Full Text] [Related]
20. Transcellular transport of organic cations in double-transfected MDCK cells expressing human organic cation transporters hOCT1/hMATE1 and hOCT2/hMATE1. Sato T; Masuda S; Yonezawa A; Tanihara Y; Katsura T; Inui K Biochem Pharmacol; 2008 Oct; 76(7):894-903. PubMed ID: 18674516 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]